Diarrheal Diseases in Europe & Central Asia

This page presents diarrheal diseases mortality data for countries in Europe & Central Asia, using age-standardized death rates per 100,000 population from the Institute for Health Metrics and Evaluation (IHME). Regional analysis reveals significant variation in disease burden between countries, reflecting differences in healthcare infrastructure, socioeconomic conditions, environmental risk factors, and public health policy implementation across Europe & Central Asia.

Diarrheal diseases — caused by a constellation of bacterial, viral, and parasitic enteropathogens including rotavirus, Vibrio cholerae, enterotoxigenic E. coli, Shigella, Cryptosporidium, and norovirus — remain a leading killer of children under five worldwide. These pathogens cause profuse watery or bloody diarrhoea that rapidly depletes body fluids and electrolytes; death occurs through hypovolaemic shock, metabolic acidosis, and electrolyte derangement, often within hours of onset in malnourished children lacking access to rehydration therapy. An estimated 400,000 children under five die from diarrheal diseases annually, down from 1.6 million in 1990 — a testament to the power of oral rehydration salts (ORS), zinc supplementation, rotavirus vaccination, and improved water and sanitation. Nevertheless, diarrheal mortality remains concentrated in sub-Saharan Africa and South Asia, where poverty, malnutrition, unsafe water, and inadequate sanitation create a vicious cycle of infection and undernutrition. Repeated diarrheal episodes in early childhood impair gut integrity and nutrient absorption, contributing to stunting and impaired cognitive development even among survivors. Europe and Central Asia benefit from relatively strong health systems and high physician density, but face ageing populations, rising non-communicable disease burdens, and persistent East-West health outcome gradients. In Europe & Central Asia, diarrheal diseases mortality is near global averages, though the region exhibits a marked gradient between Western European countries with low rates and Central Asian nations facing higher burdens.

Diarrheal disease prevention requires integrated water, sanitation, and hygiene (WASH) programmes alongside biomedical interventions. Rotavirus vaccination — now included in over 100 national immunisation schedules — has reduced rotavirus hospitalisations by 40-60% in implementing countries. Oral rehydration therapy with zinc supplementation remains the cornerstone of case management, preventing the vast majority of diarrheal deaths when accessible. Exclusive breastfeeding for the first six months provides substantial protection against enteric infections in infants.

The mortality estimates presented on this page are derived from the Global Burden of Disease (GBD) study, produced by the Institute for Health Metrics and Evaluation (IHME). The GBD synthesizes data from vital registration systems, verbal autopsies, cancer registries, and surveillance networks across more than 200 countries and territories. Death rates are expressed per 100,000 population and are age-standardized, which adjusts for differences in age structure between populations so that comparisons across countries and over time reflect genuine differences in mortality risk rather than demographic composition.

The dataset typically covers the period from 1990 to 2023, although availability varies by country and cause. When interpreting the figures for diarrheal diseases in Europe & Central Asia, note that higher age-standardized rates indicate a greater mortality burden independent of whether a country's population is older or younger. Trends over time reveal whether public health interventions, economic development, and health system improvements have reduced or increased the toll of this condition in the region.

Disease-specific death rates measure the number of deaths directly attributed to diarrheal diseases per 100,000 people, after accounting for age structure. These rates capture both the prevalence of the condition and the likelihood of a fatal outcome once affected. In Europe & Central Asia, variation across countries may reflect differences in disease prevalence, access to treatment, diagnostic capacity, and the presence of comorbidities. Examining trends alongside health expenditure and intervention coverage helps identify where policy action has been most effective.

Diarrheal Diseases Worldwide All Causes in Europe & Central Asia Compare Countries Trends Diarrheal Diseases in East Asia & Pacific Diarrheal Diseases in Latin America & Caribbean Diarrheal Diseases in Middle East, North Africa, Afghanistan & Pakistan Diarrheal Diseases in North America